CY1119845T1 - Ενα γαλακτοκομικο προϊον μειωμενης χοληστερολης για χρηση στην θεραπευτικη αντιμετωπιση και/ή προληψη μιας ασθενειας του ηπατος - Google Patents

Ενα γαλακτοκομικο προϊον μειωμενης χοληστερολης για χρηση στην θεραπευτικη αντιμετωπιση και/ή προληψη μιας ασθενειας του ηπατος

Info

Publication number
CY1119845T1
CY1119845T1 CY20171101217T CY171101217T CY1119845T1 CY 1119845 T1 CY1119845 T1 CY 1119845T1 CY 20171101217 T CY20171101217 T CY 20171101217T CY 171101217 T CY171101217 T CY 171101217T CY 1119845 T1 CY1119845 T1 CY 1119845T1
Authority
CY
Cyprus
Prior art keywords
disease
prevention
milk product
therapeutic treatment
reduced cholesterol
Prior art date
Application number
CY20171101217T
Other languages
English (en)
Inventor
Daniel Dalemans
Original Assignee
S. A. Corman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S. A. Corman filed Critical S. A. Corman
Publication of CY1119845T1 publication Critical patent/CY1119845T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C13/00—Cream; Cream preparations; Making thereof
    • A23C13/12—Cream preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A23C15/14—Butter powder; Butter oil, i.e. melted butter, e.g. ghee ; Anhydrous butter
    • A23C15/145—Removal of steroids, e.g. cholesterol or free acids; Fractionation of anhydrous milkfat by extraction with solvents other than solvent crystallisation or with supercritical gases or by distillation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C7/00—Other dairy technology
    • A23C7/04—Removing unwanted substances other than lactose or milk proteins from milk
    • A23C7/043—Removing unwanted substances other than lactose or milk proteins from milk using chemicals in liquid or solid state, e.g. flocculating, adsorbing or extracting agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

Η παρούσα εφεύρεση αναφέρεται σε ένα γαλακτοκομικό προϊόν μειωμένης χοληστερόλης, από μηρυκαστικά, ως φάρμακο.
CY20171101217T 2009-04-23 2017-11-22 Ενα γαλακτοκομικο προϊον μειωμενης χοληστερολης για χρηση στην θεραπευτικη αντιμετωπιση και/ή προληψη μιας ασθενειας του ηπατος CY1119845T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09158666 2009-04-23
PCT/EP2010/055424 WO2010122138A1 (en) 2009-04-23 2010-04-23 A reduced-cholesterol dairy product for use as a medicament
EP10721365.4A EP2421380B1 (en) 2009-04-23 2010-04-23 A reduced-cholesterol dairy product for use in the treatment and/or prevention of a liver disease

Publications (1)

Publication Number Publication Date
CY1119845T1 true CY1119845T1 (el) 2018-06-27

Family

ID=40672244

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171101217T CY1119845T1 (el) 2009-04-23 2017-11-22 Ενα γαλακτοκομικο προϊον μειωμενης χοληστερολης για χρηση στην θεραπευτικη αντιμετωπιση και/ή προληψη μιας ασθενειας του ηπατος

Country Status (25)

Country Link
US (1) US20120034308A1 (el)
EP (1) EP2421380B1 (el)
JP (1) JP5770716B2 (el)
KR (1) KR20120007058A (el)
AR (1) AR076399A1 (el)
AU (1) AU2010240858B2 (el)
BR (1) BRPI1006404B1 (el)
CA (1) CA2753784C (el)
CY (1) CY1119845T1 (el)
DK (1) DK2421380T3 (el)
ES (1) ES2648052T3 (el)
HR (1) HRP20171747T1 (el)
HU (1) HUE037345T2 (el)
LT (1) LT2421380T (el)
MX (1) MX356969B (el)
NO (1) NO2421380T3 (el)
NZ (1) NZ594821A (el)
PL (1) PL2421380T3 (el)
PT (1) PT2421380T (el)
RU (1) RU2546283C2 (el)
SI (1) SI2421380T1 (el)
TW (1) TWI589228B (el)
UA (1) UA109526C2 (el)
UY (1) UY32576A (el)
WO (1) WO2010122138A1 (el)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE862264R (fr) * 1977-12-23 1978-06-23 Nestle Sa Procede de fabrication d'un produit alimentaire du genre beurre ou margarine
US4996072A (en) * 1987-03-02 1991-02-26 General Mills, Inc. Physical process for the deodorization and/or cholesterol reduction of fats and oils
US4804555A (en) * 1986-10-21 1989-02-14 General Mills, Inc. Physical process for simultaneous deodorization and cholesterol reduction of fats and oils
US5092964A (en) * 1989-02-03 1992-03-03 Campbell Soup Company Production of low cholesterol butter oil by vapor sparging
BE1003488A3 (fr) * 1989-03-14 1992-04-07 Corman N Sa Procede de reduction de la teneur en cholesterol et en acides gras libres de la matiere grasse d'origine animale et matiere grasse ainsi obtenue.
US5340602A (en) * 1989-04-20 1994-08-23 Hermann Hoche Process for the production of low cholesterol butterfat or butter
ATE110522T1 (de) * 1989-04-20 1994-09-15 Hermann Hoche Verfahren zur herstellung von cholesterin- reduziertem tierischem fett, insbesondere butterfett bzw. butter, sowie anlage zu deren herstellung.
FR2648988B1 (fr) * 1989-06-29 1991-10-18 Roquette Freres Procede de fabrication de produits laitiers a teneur reduite en sterols, et produits ainsi obtenus
US5175015A (en) 1990-01-30 1992-12-29 Rich Products Corporation Process of making low fat low cholesterol milk products
JPH03229800A (ja) * 1990-02-05 1991-10-11 Snow Brand Milk Prod Co Ltd コレステロール含量を低減した動物性油脂の製造方法
US5378487A (en) 1993-03-17 1995-01-03 Kraft General Foods, Inc. Oil extraction of cholesterol from milk products
US6630192B2 (en) * 1995-04-07 2003-10-07 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids
CA2242301A1 (en) 1996-11-07 1998-05-14 Kyowa Hakko Kogyo Co., Ltd. Process for producing a cholestrol-reduced substance
US6303803B1 (en) * 1997-01-31 2001-10-16 Cargill, Incorporated Removal of sterols from fats and oils
US6110517A (en) * 1997-08-02 2000-08-29 Se Jong University Method for removing cholesterol from milk and cream
AU2002361461A1 (en) 2002-12-10 2004-06-30 Rajeev Vijay Hiremath Producing cholesterolfree meat, egg and milk
US7968529B2 (en) 2003-01-20 2011-06-28 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Use of sphingolipids for reducing high plasma cholesterol and high triacylglycerol levels
US20040191294A1 (en) * 2003-03-27 2004-09-30 Ramaprasad Talahalli Ravichandra Health composition
KR100791978B1 (ko) * 2005-06-21 2008-01-04 곽해수 콜레스테롤 제거용 베타-싸이클로덱스트린의 가교화 및그의 재생방법
DK1983989T3 (da) * 2006-02-09 2013-10-14 Ca Nat Research Council Kombinationer af botaniske ekstrakter til fremme af kardiovaskulær sundhed
US8461130B2 (en) * 2006-12-28 2013-06-11 Ezaki Glico Co., Ltd. Food containing glycogen and use thereof
EP2055195A1 (fr) * 2007-10-29 2009-05-06 Corman S.A. Procédé de reduction de la teneur en acides gras saturés de la matiere grasse du lait , produits obtenus et applications de ceux-ci.

Also Published As

Publication number Publication date
US20120034308A1 (en) 2012-02-09
PL2421380T3 (pl) 2018-02-28
WO2010122138A1 (en) 2010-10-28
LT2421380T (lt) 2017-12-11
RU2011138722A (ru) 2013-05-27
CA2753784A1 (en) 2010-10-28
TW201039755A (en) 2010-11-16
KR20120007058A (ko) 2012-01-19
NO2421380T3 (el) 2018-01-20
PT2421380T (pt) 2017-11-16
HRP20171747T1 (hr) 2017-12-29
AU2010240858B2 (en) 2015-05-28
HUE037345T2 (hu) 2018-08-28
CN102413703A (zh) 2012-04-11
TWI589228B (zh) 2017-07-01
AU2010240858A1 (en) 2011-09-15
BRPI1006404B1 (pt) 2018-05-29
JP2012524533A (ja) 2012-10-18
ES2648052T3 (es) 2017-12-28
BRPI1006404A2 (pt) 2015-08-25
UA109526C2 (uk) 2015-09-10
SI2421380T1 (en) 2018-01-31
MX356969B (es) 2018-06-21
CA2753784C (en) 2017-09-05
AR076399A1 (es) 2011-06-08
NZ594821A (en) 2014-05-30
MX2011011128A (es) 2011-11-18
UY32576A (es) 2010-11-30
DK2421380T3 (en) 2017-12-04
JP5770716B2 (ja) 2015-08-26
EP2421380B1 (en) 2017-08-23
EP2421380A1 (en) 2012-02-29
RU2546283C2 (ru) 2015-04-10

Similar Documents

Publication Publication Date Title
CY1120102T1 (el) Συνθεσεις και μεθοδοι για μειωση τριγλυκεριδιων χωρις αυξηση επιπεδων ldl-c σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης
CY1117372T1 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες και η χρηση τους
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
PH12015500407A1 (en) Methods of treating hypertriglyceridemia
MX2013006591A (es) Formas farmaceuticas orales de liberacion controlada de farmacos escasamente solubles y los usos de estas.
UA109650C2 (xx) Біс-арилзв'язані арилтриазолони та їх застосування
EA201390060A1 (ru) Аннелированные пиримидины и триазины и их применение для лечения и/или профилактики сердечно-сосудистых заболеваний
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
TN2014000175A1 (en) Novel purine derivatives and their use in the treatment of disease
IN2012DN06720A (el)
CY1120094T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει despr036 eξenδinh-4(1-39)-lys6-nh2 για χρηση στην θεραπευτικη αγωγη μιας νευροεκφυλιστικης ασθενειας
MX2019003249A (es) Diagnostico, prevencion y tratamiento de enfermedades de la articulacion.
MX2014002171A (es) Tratamientos de combinacion para hepatitis c.
MX356728B (es) Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2.
AR089862A1 (es) USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA
PL2771329T3 (pl) Nowe związki di-podstawione 3,4-diamino-3-cyklobuteno- 1,2-dionu do zastosowania w leczeniu patologii, w których pośredniczą chemokiny
MX2014005209A (es) Un medicamento para tratar la enfermedad del ojo anterior que comprende rebamipida y un agente de retencion de lagrimas.
EA201290603A1 (ru) Способ лечения
EA201190312A1 (ru) Замещенные пиперидины
CY1116234T1 (el) Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
WO2010135521A3 (en) Compositions and methods for the therapy and diagnosis of influenza
PH12014501290A1 (en) Methods and products to diagnose and treat heatiness
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
MX2013010367A (es) Composiciones y metodos para la terapia y diagnostico de influenza.